Molecular design and synthesis of HCV inhibitors based on thiazolone scaffold
Authors:
- Ghada H. Al-AnsaryGAGhada H. Al-Ansary
- Mohamed A.H. IsmailMIMohamed A.H. Ismail
- Dalal A. Abou El EllaDEDalal A. Abou El Ella
- Sameh EidSESameh Eid
- Khaled A.M. AbouzidKAKhaled A.M. Abouzid
- 1 October 2013
- journal article
- Published by Elsevier in European Journal of Medicinal Chemistry
- Vol. 68, 19-32
Abstract
No abstract availableKeywords
This publication has 32 references indexed in Scilit:
- Hepatitis C Treatment: current and future perspectivesVirology Journal, 2010
- Hepatitis C virus directly acting antivirals: current developments with NS3/4A HCV serine protease inhibitorsJournal of Antimicrobial Chemotherapy, 2010
- Hepatitis C: recent successes and continuing challenges in the development of improved treatment modalitiesCurrent Opinion in Pharmacology, 2009
- Global epidemiology of hepatitis C virus infectionThe Lancet Infectious Diseases, 2005
- Efficacy of a 24-week course of PEG-interferon α-2b monotherapy in patients with acute hepatitis C after failure of spontaneous clearanceJournal of Hepatology, 2005
- Treatment of Acute Hepatitis C with Interferon Alfa-2bNew England Journal of Medicine, 2001
- Semianalytical treatment of solvation for molecular mechanics and dynamicsJournal of the American Chemical Society, 1990
- A kinetic study of the Friedel–Crafts reaction of naphthalene with para-substituted benzenesulphonyl chlorides; the effect of the substituentJournal of the Chemical Society, Perkin Transactions 2, 1988
- N-Heterocyclic BenzenesulfonamidesJournal of the American Chemical Society, 1951
- Identification of Organic Compounds. I. Chlorosulfonic Acid as a Reagent for the Identification of Aryl HalidesJournal of the American Chemical Society, 1940